Trial · NCT03005288
Adverse events250
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
201 to 220 of 250
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Menorrhagia | Reproductive system and breast disorders | BYM338 10 mg/kg | 1 | 37 | |
| other | Menorrhagia | Reproductive system and breast disorders | Placebo | 0 | 38 | |
| other | Postmenopausal haemorrhage | Reproductive system and breast disorders | BYM338 10 mg/kg | 1 | 37 | |
| other | Postmenopausal haemorrhage | Reproductive system and breast disorders | Placebo | 0 | 38 | |
| other | Cough | Respiratory, thoracic and mediastinal disorders | BYM338 10 mg/kg | 0 | 37 | |
| other | Cough | Respiratory, thoracic and mediastinal disorders | Placebo | 2 | 38 | |
| other | Dyspnoea exertional | Respiratory, thoracic and mediastinal disorders | BYM338 10 mg/kg | 0 | 37 | |
| other | Dyspnoea exertional | Respiratory, thoracic and mediastinal disorders | Placebo | 1 | 38 | |
| other | Epistaxis | Respiratory, thoracic and mediastinal disorders | BYM338 10 mg/kg | 1 | 37 | |
| other | Epistaxis | Respiratory, thoracic and mediastinal disorders | Placebo | 0 | 38 | |
| other | Sinus congestion | Respiratory, thoracic and mediastinal disorders | BYM338 10 mg/kg | 1 | 37 | |
| other | Sinus congestion | Respiratory, thoracic and mediastinal disorders | Placebo | 0 | 38 | |
| other | Acne | Skin and subcutaneous tissue disorders | BYM338 10 mg/kg | 1 | 37 | |
| other | Acne | Skin and subcutaneous tissue disorders | Placebo | 0 | 38 | |
| other | Alopecia | Skin and subcutaneous tissue disorders | BYM338 10 mg/kg | 0 | 37 | |
| other | Alopecia | Skin and subcutaneous tissue disorders | Placebo | 2 | 38 | |
| other | Blister | Skin and subcutaneous tissue disorders | BYM338 10 mg/kg | 1 | 37 | |
| other | Blister | Skin and subcutaneous tissue disorders | Placebo | 0 | 38 | |
| other | Dermatitis | Skin and subcutaneous tissue disorders | BYM338 10 mg/kg | 0 | 37 | |
| other | Dermatitis | Skin and subcutaneous tissue disorders | Placebo | 1 | 38 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03005288/events?page=11